Noninferiority of <sup>99m</sup>Tc-Ethylenedicysteine-Glucosamine as an Alternative Analogue to <sup>18</sup>F-Fluorodeoxyglucose in the Detection and Staging of Non-Small Cell Lung Cancer

<div>Whole-body planar biodistribution images of <svg height="11.6412pt" id="M31" style="vertical-align:-0.04979992pt" version="1.1" viewbox="-0.0498162 -11.5914 17.1122 11.6412" width="17.1122pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0091,0,0,-0.0091,0,-5.741)"><path d="M247 635C116 635 39 518 39 421C39 315 113 237 221 237C239 237 258 241 281 253L349 289C315 140 204 42 60 19L66 -15C90 -15 153 -5 207 16C344 70 447 199 447 385C447 521 373 635 247 635ZM231 598C329 598 356 478 356 390C356 371 355 347 352 325C330 309 297 297 262 297C179 297 127 369 127 456C127 515 156 598 231 598Z" id="g50-58"></path></g><g transform="matrix(.0091,0,0,-0.0091,4.433,-5.741)"><path d="M247 635C116 635 39 518 39 421C39 315 113 237 221 237C239 237 258 241 281 253L349 289C315 140 204 42 60 19L66 -15C90 -15 153 -5 207 16C344 70 447 199 447 385C447 521 373 635 247 635ZM231 598C329 598 356 478 356 390C356 371 355 347 352 325C330 309 297 297 262 297C179 297 127 369 127 456C127 515 156 598 231 598Z" id="g50-58"></path></g><g transform="matrix(.0091,0,0,-0.0091,8.897,-5.741)"><path d="M810 0V30C751 35 744 40 744 106V296C744 396 694 451 614 451C583 451 558 438 537 425C512 409 485 391 454 368C434 420 390 451 342 451C309 451 285 439 260 424C228 405 206 387 185 372V453C141 434 90 421 43 413V386C102 378 105 373 105 309V106C105 41 96 35 29 30V0H243V30C194 35 185 41 185 106V335C216 360 256 389 297 389C357 389 384 348 384 275V106C384 41 374 35 312 30V0H530V30C475 35 465 41 465 104V294C465 313 464 324 463 336C502 367 539 389 576 389C637 389 663 346 663 274V109C663 41 653 35 593 30V0H810Z" id="g58-107"></path></g></svg>Tc-EC-G at 15, 30, 60, 120, and 240 minutes after injection. Note absence of activity in the brain, heart, and bone.</div>

Contrast Media & Molecular Imaging

fig4

Figure 4

Figure 4: Noninferiority of <sup>99m</sup>Tc-Ethylenedicysteine-Glucosamine as an Alternative Analogue to <sup>18</sup>F-Fluorodeoxyglucose in the Detection and Staging of Non-Small Cell Lung Cancer 

Figure 4 | Noninferiority of 99mTc-Ethylenedicysteine-Glucosamine as an Alternative Analogue to 18F-Fluorodeoxyglucose in the Detection and Staging of Non-Small Cell Lung Cancer 